Gracell Biotechnologies Inc. - American Depositary Shares (NQ:GRCL)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 21, 2024 Add to My Watchlist

Price and Volume

Volume	0
Open	-
Bid (Size)	10.22 (49)
Ask (Size)	10.41 (10)
Prev. Close	10.25
Today's Range	N/A - N/A
52wk Range	N/A - N/A
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Gracell Biotechnologies Acquisition Completed

February 22, 2024

From Gracell Biotechnologies Inc.

Via GlobeNewswire

Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement

February 20, 2024

From Gracell Biotechnologies Inc.

Via GlobeNewswire

Performance

More News

Gracell Biotechnologies Inc. (NASDAQ: GRCL) is a Stock Spotlight on 2/7

February 07, 2024

Via Investor Brand Network

Health Care Company AstraZeneca Announces Acquisition of Gracell Biotechnologies ↗

December 26, 2023

Via Benzinga

Week In Review: Shanghai Inmagene Signs $230 Million Deal To Develop Two HutchMed Immunology Assets ↗

February 03, 2024

Via Talk Markets

Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma

January 29, 2024

From Gracell Biotechnologies Inc.

Via GlobeNewswire

Focus On Bristol Myers, Gilead Sciences, Johnson & Johnson, Novartis: FDA To Issue Classwide Black Box Warning on CAR-T Therapies For Blood Cancer Treatment ↗

January 23, 2024

Via Benzinga

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

January 16, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

AstraZeneca: Rebound in 2024 with double-digit earnings growth

January 11, 2024

Via MarketBeat

January 08, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

With its sale to AstraZeneca, Gracell blazes exit trail for cash-challenged Chinese biotechs ↗

January 05, 2024

Via Benzinga

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024 ↗

January 05, 2024

Via Investor's Business Daily

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RayzeBio, Inc. (Nasdaq – RYZB), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Daseke, Inc. (Nasdaq – DSKE), Karuna Therapeutics, Inc. (Nasdaq – KRTX)

January 04, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

GRACELL BIOTECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Gracell Biotechnologies Inc. - GRCL

December 31, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

Week In Review: $1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal ↗

December 31, 2023

Via Talk Markets

Stock Market Ending 2023 On High Note; Tesla, Drug M&A In Focus: Weekly Review ↗

December 29, 2023

Via Investor's Business Daily

Investor Sentiment Improves; Dow Jumps Over 150 Points ↗

December 27, 2023

Via Benzinga

December 26, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher ↗

December 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 26, 2023

Via Benzinga

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 26, 2023

Via Benzinga

Crude Oil Rises Over 3%; US Home Prices Increase In October ↗

December 26, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 26, 2023

Via Benzinga

Why Sentage Holdings Shares Are Trading Lower By 5%; Here Are 20 Stocks Moving Premarket ↗

December 26, 2023

Via Benzinga

US Stocks Set To Start Final Trading Week Of Year On Positive Note As Santa Claus Rally Gets Going: Analyst Confident Of Market Finishing Year At Highs ↗

December 26, 2023

Via Benzinga

Frequently Asked Questions

Is Gracell Biotechnologies Inc. - American Depositary Shares publicly traded?

Yes, Gracell Biotechnologies Inc. - American Depositary Shares is publicly traded.

What exchange does Gracell Biotechnologies Inc. - American Depositary Shares trade on?

Gracell Biotechnologies Inc. - American Depositary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Gracell Biotechnologies Inc. - American Depositary Shares?

The ticker symbol for Gracell Biotechnologies Inc. - American Depositary Shares is GRCL on the Nasdaq Stock Market